Pharmacogenetics and human genetic polymorphisms

The Biochemical Journal
Ann K Daly

Abstract

The term pharmacogenetics was first used in the late 1950s and can be defined as the study of genetic factors affecting drug response. Prior to formal use of this term, there was already clinical data available in relation to variable patient responses to the drugs isoniazid, primaquine and succinylcholine. The subject area developed rapidly, particularly with regard to genetic factors affecting drug disposition. There is now comprehensive understanding of the molecular basis for variable drug metabolism by the cytochromes P450 and also for variable glucuronidation, acetylation and methylation of certain drugs. Some of this knowledge has already been translated to the clinic. The molecular basis of variation in drug targets, such as receptors and enzymes, is generally less well understood, although there is consistent evidence that polymorphisms in the genes encoding the beta-adrenergic receptors and the enzyme vitamin K epoxide reductase is of clinical importance. The genetic basis of rare idiosyncratic adverse drug reactions had also been examined. Susceptibility to reactions affecting skin and liver appears to be determined in part by the HLA (human leucocyte antigen) genotype, whereas reactions affecting the heart and muscl...Continue Reading

References

Sep 17, 1977·Lancet·A MahgoubR L Smith
May 1, 1979·Clinical Pharmacokinetics·A F MacklonM D Rawlins
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Jan 1, 1979·Diabetes·J Scott, P L Poffenbarger
Jan 1, 1977·Drug Metabolism Reviews·F J Di Carlo
Oct 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·F J WiebelM J Coon
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M BlumU A Meyer
Aug 8, 1991·Biochemical Pharmacology·D Hickman, E Sim
Feb 1, 1990·Nature·J L Goldstein, M S Brown
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·K P VatsisW W Weber
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A Hirono, E Beutler
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J SeidegårdW R Pearson
Dec 10, 1987·Nucleic Acids Research·S KimuraF J Gonzalez
Jun 25, 1970·The New England Journal of Medicine·R A O'Reilly
Jan 1, 1984·European Journal of Clinical Pharmacology·A Küpfer, R Preisig
May 1, 1982·British Journal of Clinical Pharmacology·G C KahnD S Davies
Nov 1, 1982·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D E RyanW Levin
Feb 1, 1980·European Journal of Clinical Pharmacology·L BertilssonH U Schulz
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·I JohanssonM Ingelman-Sundberg
Aug 1, 1996·Pharmacogenetics·T H Sullivan-KloseJ A Goldstein
Oct 23, 1997·Nature Biotechnology·A Marshall
Nov 14, 1997·Pharmacogenetics·D J StewardA E Rettie
May 23, 1998·BMJ : British Medical Journal·M PirmohamedB K Park
May 20, 1998·Clinical Pharmacology and Therapeutics·P DalénL Bertilsson
Apr 23, 1999·The Journal of Biological Chemistry·D A MasonS B Liggett
Oct 27, 1999·Gastroenterology·M L HautekeeteA P Geubel
Mar 15, 2000·Proceedings of the National Academy of Sciences of the United States of America·S HoffmeyerU Brinkmann
Sep 14, 2000·Proceedings of the National Academy of Sciences of the United States of America·C M DrysdaleS B Liggett

❮ Previous
Next ❯

Citations

Dec 1, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Marco ZaffanelloGiovanni Malerba
Feb 2, 2013·Nature Reviews. Drug Discovery·Marc MaliepaardMarkus Paulmichl
May 4, 2012·Journal of the Royal Society, Interface·Jennifer L LahtiRuss B Altman
Jun 11, 2011·Breast Cancer Research : BCR·Sumit ParmarElisabeth Haschke-Becher
May 17, 2012·CNS Drugs·Albert J Arias, R Andrew Sewell
Feb 22, 2011·Pharmacogenomics·Markus R Meyer, Hans H Maurer
Jun 23, 2011·Pharmacogenomics·Jean-Étienne MorlighemAlexander Lezhava
Nov 29, 2011·Pharmacogenomics·Issam ZinehMichael A Pacanowski
Mar 8, 2011·Yi chuan = Hereditas·Jian-Wen Han, Xue-Jun Zhang
Jun 8, 2011·Future Medicinal Chemistry·Leposava Antonovic, Marilyn Martinez
Nov 13, 2012·Annual Review of Pharmacology and Toxicology·Urs A MeyerMatthias Schwab
Dec 9, 2014·Biological Psychiatry·Steven P Hamilton
Mar 23, 2011·Expert Opinion on Drug Metabolism & Toxicology·Glynn A MorrishBruce Green
Dec 4, 2013·The Nursing Clinics of North America·Stephen D Krau
Dec 4, 2013·The Nursing Clinics of North America·Stephen D Krau
Aug 13, 2011·The Journal of Sexual Medicine·Monica L AndersenSergio Tufik
Jun 16, 2011·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·Sanjay Harrison, Harrison Benziger
Apr 12, 2011·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Jun ZhangGenfa Zhang
May 17, 2011·Expert Opinion on Pharmacotherapy·Mariano A GiorgiGuillermo Di Girolamo
Oct 9, 2014·Journal of Genetic Counseling·Rachel J RiesgrafBonnie S LeRoy
Jun 23, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Lateef M KhanAhmed S Ali
Aug 23, 2016·Pharmacogenomics·Judit KumuthiniAlessio Squassina
May 17, 2011·Accountability in Research·R H SijmonsJ G Sijmons
Nov 14, 2017·Epigenomics·John P ThomsonRichard R Meehan
Mar 23, 2018·Journal of Alzheimer's Disease : JAD·Harald HampelUNKNOWN Alzheimer Precision Medicine Initiative (APMI)
May 1, 2014·Personalized Medicine·Beth McNallyRoland Valdes
Mar 14, 2017·Climacteric : the Journal of the International Menopause Society·H HampelUNKNOWN Alzheimer Precision Medicine Initiative
Nov 24, 2020·Expert Opinion on Drug Metabolism & Toxicology·Camilla StephensRaúl J Andrade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

© 2021 Meta ULC. All rights reserved